Yahoo Αναζήτηση Διαδυκτίου

Sign In

Αποτελέσματα Αναζήτησης

  1. www.fda.gov › coronavirus-disease-2019-covid-19 › covid-19-vaccinesCOVID-19 Vaccines | FDA - U.S. Food and Drug Administration

    FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age. The FDA amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and...

  2. www.nejm.org › doi › fullEvaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years...

    19 Οκτ 2022 · Two 25-μg doses of the mRNA-1273 vaccine were found to be safe in children 6 months to 5 years of age and elicited immune responses that were noninferior to those in young adults.

  3. www.cdc.gov › mmwr › volumesInterim Recommendations of the Advisory Committee on Immunization...

    30 Ιουν 2022 · On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months–5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 weeks apart, and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine for use in children aged 6 months ...

  4. www.cdc.gov › acip › evidence-to-recommendationsACIP Evidence to Recommendations for Use of Moderna COVID-19...

    5 Σεπ 2024 · On June 17, 2022, the Food and Drug Administration (FDA) authorized an Emergency Use Authorization (EUA) for a 2-dose Moderna COVID-19 vaccine primary series for administration to children ages 6 months through 5 years. The FDA also authorized a 3rd primary series dose of the Moderna COVID-19 vaccine to children ages 6 months through 5 years ...

  5. jamanetwork.com › journals › jamaPediatric COVID-19 Vaccines : What Parents ... - JAMA Network

    The US Food and Drug Administration (FDA) granted Emergency Use Authorization for Pfizer-BioNTech’s mRNA COVID-19 vaccine (BNT162b2) for children 5 to 11 years of age on October 29, 2021. The Centers for Disease Control and Prevention recommended use of the vaccine among children in this age group on November 2, 2021.

  6. publications.aap.org › pediatrics › articleCOVID-19 Vaccines in Infants, Children, and Adolescents

    29 Αυγ 2022 · The American Academy of Pediatrics (AAP) recommends coronavirus disease 2019 (COVID-19) vaccination for all infants, children, and adolescents 6 months of age and older who do not have contraindications to receiving a COVID-19 vaccine authorized or approved for use for their age.

  7. pubmed.ncbi.nlm.nih.gov › 34968370COVID-19 Vaccine Safety in Children Aged 5-11 Years - PubMed

    31 Δεκ 2021 · On October 29, 2021, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for Pfizer-BioNTech COVID-19 (BNT162b2) mRNA vaccine to expand its use to children aged 5-11 years, administered as 2 doses (10 μg, 0.2mL each) 3 weeks apart (1).